XML 13 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Oct. 28, 2023
Oct. 29, 2022
Oct. 28, 2023
Oct. 29, 2022
Net sales $ 1,026,677 $ 1,204,281 $ 3,289,615 $ 3,925,216
Cost of sales (exclusive of depreciation expense shown separately below) 652,862 794,821 2,147,447 2,572,614
Gross margin 373,815 409,460 1,142,168 1,352,602
Selling and administrative expenses 525,730 503,016 1,606,678 1,495,848
Depreciation expense 33,122 37,255 110,986 111,808
Gain on sale of real estate and related expenses (204,719) 0 (211,912) (1,609)
Operating income (loss) 19,682 (130,811) (363,584) (253,445)
Interest expense (13,592) (6,256) (33,916) (12,910)
Other income (expense) 0 62 5 1,359
Income (loss) before income taxes 6,090 (137,005) (397,495) (264,996)
Income tax expense (benefit) 1,347 (33,992) 53,672 (66,751)
Net income (loss) and comprehensive income (loss) $ 4,743 $ (103,013) $ (451,167) $ (198,245)
Earnings (loss) per common share        
Earnings (loss) per common share - basic (in dollars per share) $ 0.16 $ (3.56) $ (15.49) $ (6.88)
Earnings (loss) per common share - diluted (in dollars per share) $ 0.16 $ (3.56) $ (15.49) $ (6.88)
Weighted-average common shares outstanding:        
Basic 29,204 28,943 29,132 28,828
Dilutive effect of share-based awards 96 0 0 0
Diluted 29,300 28,943 29,132 28,828
Cash dividends declared per common share $ 0 $ 0.30 $ 0.30 $ 0.90